2001
DOI: 10.1016/s0925-4773(01)00428-2
|View full text |Cite
|
Sign up to set email alerts
|

Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2

Abstract: Vascular endothelial growth factor (VEGF) is a critical regulator of angiogenesis during development, but little is known about the factors that control its expression. We provide the first example of tissue specific loss of VEGF expression as a result of targeting a single gene, Cbfa1/Runx2. During endochondral bone formation, invasion of blood vessels into cartilage is associated with upregulation of VEGF in hypertrophic chondrocytes and increased expression of VEGF receptors in the perichondrium. This upreg… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

14
254
0
3

Year Published

2001
2001
2020
2020

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 305 publications
(273 citation statements)
references
References 49 publications
14
254
0
3
Order By: Relevance
“…Whether CMYC and hypoxia common target genes play a role in leukemogenesis remains to be determined. It has been proposed that AML3, a CBFA subunit specific for bone tissue, is involved in the control of the cellular response to hypoxia (Zelzer et al, 2001). Consistently, a crosstalk between AML1-ETO and the cellular response to hypoxia has recently been described, impacting on the transcriptional control of cellular differentiation (Jiang et al, 2005).…”
Section: Discussionmentioning
confidence: 90%
“…Whether CMYC and hypoxia common target genes play a role in leukemogenesis remains to be determined. It has been proposed that AML3, a CBFA subunit specific for bone tissue, is involved in the control of the cellular response to hypoxia (Zelzer et al, 2001). Consistently, a crosstalk between AML1-ETO and the cellular response to hypoxia has recently been described, impacting on the transcriptional control of cellular differentiation (Jiang et al, 2005).…”
Section: Discussionmentioning
confidence: 90%
“…Moreover, this recruitment is under the influence of a major angiogenic factor, VEGF [42]. VEGF is made by the terminal hypertrophic chondrocytes under the control of Runx-2 [43] and is linked to the expression of another angiogenic factor, connective tissue growth factor (CTGF) [44]. The injection of a soluble VEGF receptor, the mFlt-1-Fc containing the terminal three Ig repeats of the receptor fused to the Fc portion of IgG, phenocopies the growth plate phenotype of MMP9 −/− mice [45].…”
Section: Mmp9 Is a Key Regulator Of Early Growth Plate Angiogenesis Amentioning
confidence: 99%
“…However, this is unlikely because the progression of hypertrophic differentiation can be observed during formation of the secondary center of ossification in the distal epiphyses of MT2-5. Further investigations using the metatarsal model of VEGF protein expression (Zelzer et al, 2001(Zelzer et al, , 2002Maes et al, 2004) and other factors known to regulate chondrocyte hypertrophy and angiogenesis (Schipani et al, 2001) may resolve these issues.…”
Section: Comparative Histomorphology Of Growth Plate Formation and DImentioning
confidence: 99%